Abbott Laboratories (NYSE:ABT) Earns Overweight Rating from Analysts at Piper Sandler
Piper Sandler assumed coverage on shares of Abbott Laboratories (NYSE:ABT – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $131.00 price objective on the healthcare product maker’s stock. A number of other brokerages have also recently issued reports on ABT. Citigroup raised their […]
23 Sep 05:53 · The Markets Daily